PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

phentermine Side Effects

The reactions most often reported to the FDA for phentermine (also sold as Adipex-P, Lomaira), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

6,109
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of phentermine come from 6,109 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 6,109 reports to the FDA Adverse Event Reporting System (FAERS) for phentermine (Adipex-P): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

6,109

Reports Mentioning Death

390

6.4% of reports — not proof the medicine caused the death

Hospitalizations

1,481

24.2% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

NAUSEA
475
PAIN
462
FATIGUE
346
HEADACHE
335
ANXIETY
312
VOMITING
237
DIZZINESS
224
CHRONIC KIDNEY DISEASE
204
DIARRHOEA
203
WEIGHT INCREASED
203
DYSPNOEA
193
DEPRESSION
191
ARTHRALGIA
180
ABDOMINAL PAIN
165
INSOMNIA
162
ACUTE KIDNEY INJURY
160
RASH
158
INJURY
155

Who Reports Side Effects

Gender Distribution

Female 4,729 (85%)
Male 772 (14%)
Unknown 92

Age Distribution

0-17 51 (1%)
18-44 1,819 (47%)
45-64 1,667 (43%)
65-74 251 (7%)
75+ 54 (1%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 390 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
COMPLETED SUICIDE 95
DRUG ABUSE 91
TOXICITY TO VARIOUS AGENTS 77
DEATH 60
CARDIO-RESPIRATORY ARREST 43
CARDIAC ARREST 42
RESPIRATORY ARREST 33
OVERDOSE 17
POISONING 15
ACUTE KIDNEY INJURY 12
SUSPECTED SUICIDE 12
HYPOTENSION 10
INTENTIONAL DRUG MISUSE 9
METABOLIC ACIDOSIS 9
COMA 8
DEPRESSED LEVEL OF CONSCIOUSNESS 7
DRUG TOXICITY 7
HYPOGLYCAEMIA 7
PULMONARY EMBOLISM 7
RHABDOMYOLYSIS 7

Reactions in Hospitalization Reports

Top reactions in 1,481 reports where hospitalization was an outcome.

Reaction Reports
PAIN 186
NAUSEA 154
ANXIETY 134
PULMONARY EMBOLISM 127
INJURY 110
VOMITING 100
DEEP VEIN THROMBOSIS 98
ABDOMINAL PAIN 90
DYSPNOEA 86
CHOLECYSTITIS CHRONIC 83
HEADACHE 81
ACUTE KIDNEY INJURY 79
FATIGUE 75
EMOTIONAL DISTRESS 74
CHEST PAIN 72
DEPRESSION 70
CHOLELITHIASIS 67
DIARRHOEA 65
DRUG INTERACTION 65

Compare phentermine vs acarbose →

What the FAERS Data Reveals About phentermine Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 6,109 voluntary reports linked to phentermine and its brand equivalents (Adipex-P, Lomaira), spanning 2004 through 2025. Of those, 390 (6.4%) listed death as an outcome and 1,481 (24.2%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 85% were female and 14% male; age distribution skews toward 18-44, with 1,819 reports in that bracket. The single most reported reaction is nausea with 475 submissions, followed by pain and fatigue.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.